KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash from Financing Activities (2016 - 2025)

Astrana Health's Cash from Financing Activities history spans 15 years, with the latest figure at $648.5 million for Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 20428.87% year-over-year to $648.5 million; the TTM value through Sep 2025 reached $580.4 million, up 257.39%, while the annual FY2024 figure was $135.1 million, 3850.48% up from the prior year.
  • Cash from Financing Activities for Q3 2025 was $648.5 million at Astrana Health, up from -$8.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $648.5 million in Q3 2025 and bottomed at -$44.2 million in Q1 2025.
  • The 5-year median for Cash from Financing Activities is -$963000.0 (2023), against an average of $35.1 million.
  • The largest annual shift saw Cash from Financing Activities plummeted 1434.4% in 2023 before it soared 20428.87% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $1.4 million in 2021, then skyrocketed by 309.13% to $5.9 million in 2022, then skyrocketed by 104.28% to $12.0 million in 2023, then tumbled by 227.3% to -$15.3 million in 2024, then skyrocketed by 4347.66% to $648.5 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Cash from Financing Activities are $648.5 million (Q3 2025), -$8.6 million (Q2 2025), and -$44.2 million (Q1 2025).